PartsTable TECHNICAL DATA SHEET
NSN 6505-01-693-4057Government record, cited

Amifampridine Phosphate Tablets6505-01-693-4057

NSN 6505-01-693-4057 · NIIN 016934057 · Part number NDC69616-0211-06
Catalyst Pharmaceuticals, Inc · FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment · CAGE 5UTL7
Government record, cited
NSN 6505-01-693-4057 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-693-4057. Manufacturer of record part number: NDC69616-0211-06.
Also searched as  6505-01-693-4057 · 6505016934057 · NIIN 016934057 · 01-693-4057 · FSC 6505 Drugs and Biologicals · CAGE 5UTL7 · NDC69616-0211-06 · 6505NCM216858 · 1580107 · FIRDAPSE
Nearby stock numbers  ·
Features
  • Amifampridine Phosphate Tablets — FSC 6505
  • 1 manufacturer part number on file
  • Manufacturer of record: Catalyst Pharmaceuticals, Inc
Identification
  • NSN: 6505-01-693-4057
  • NIIN: 016934057
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
  • Primary part number: NDC69616-0211-06
  • Manufacturer: Catalyst Pharmaceuticals, Inc
General Description

The Amifampridine Phosphate Tablets, cataloged under National Stock Number 6505-01-693-4057, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Catalyst Pharmaceuticals, Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.

Technical Specifications
ParameterValue
NSN6505-01-693-4057
Primary Part NumberNDC69616-0211-06
Item NameAmifampridine Phosphate Tablets
FSC / FSG6505 / 65 — Drugs and Biologicals
ManufacturerCatalyst Pharmaceuticals, Inc
StatusACTIVE
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssueBX
Cross-Reference Index
Part NumberManufacturer
NDC69616-0211-06 PRIMARY Catalyst Pharmaceuticals, Inc (USA)
Reference documents
ReferenceMeaning
6505NCM216858 5/1 Secondary reference
Defense Medical Standardization Board
1580107 5/1 Secondary reference
U.S. Government activity
FIRDAPSE 5/1 Secondary reference
Catalyst Pharmaceuticals, Inc
No interchangeability data on file.
Other items in FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073
6505-00-000-0073 · Item name not on file
6505-00-000-0110
6505-00-000-0110 · Item name not on file
6505-00-000-0134
6505-00-000-0134 · Item name not on file
6505-00-000-0135
6505-00-000-0135 · Item name not on file
6505-00-001-3344
6505-00-001-3344 · Item name not on file
6505-00-001-3345
FLUORESCEIN SODIUM AND BENOXINAT
6505-00-001-3346
6505-00-001-3346 · Item name not on file
6505-00-001-3347
6505-00-001-3347 · Item name not on file

Frequently Asked Questions

What is NSN 6505-01-693-4057?

NSN 6505-01-693-4057 is a Amifampridine Phosphate Tablets, manufactured by Catalyst Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.

What part numbers are listed for NSN 6505-01-693-4057?

NSN 6505-01-693-4057 has 1 manufacturer part number on file: NDC69616-0211-06 (Catalyst Pharmaceuticals, Inc).

What are the specifications of NDC69616-0211-06?

Key specifications for NDC69616-0211-06: Special Features: A POTASSIUM CHANNEL BLOCKER INDICATED FOR THE TREATMENT OF LAMBERT-EASTON MYASTHENIC SYNDROME (LEMS) IN ADULTS; ORAL TABLETS 10 MG; BOX CONTAINS 12 BLISTER PACKS OF 10 TABLETS EACH (120 TABLETS TOTAL); STORE TABLETS AT 20 C TO 25 C (68 F TO 77 F) WITH EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); CHILD RESISTANT BLISTER PACK.; Part Name Assigned by Controlling Agency: AMIFAMPRIDINE PHOSPHATE TABLETS, 10MG, 120S. 0 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-693-4057 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com